In the U.S., the Versius Surgical System is indicated for adult patients 22 years of age and older, eligible for soft-tissue minimal-access surgery, for cholecystectomy. | Source: CMR Surgical
CMR Surgical Ltd. last week announced that it has closed a financing round of more than $200 million through a combination of equity and debt capital. The company said surgeons have already used its Versius Surgical Robotic System to complete more than 30,000 cases in over 30 countries.
“CMR is a competitive, well-established company with a transformative product providing clear clinical value,” stated Massimiliano Colella, CEO of CMR Surgical. “We are now at a pivotal stage, poised to capitalize on significant opportunities for market expansion, including in the U.S., while continuing to penetrate deeper into existing markets.”
Founded in 2014, CMR has worked with surgeons, surgical teams, and hospital partners to develop a tool to make minimal access surgery (MAS) more accessible and affordable. Versius has a compact, portable, and modular design to fit into virtually any operating room, according to the Cambridge, U.K.-based company.
Versius provides surgical options
Biomimicking the human arm, Versius lets surgeons optimize port placement. It also offers the dexterity and accuracy of small, fully-wristed instruments, said CMR Surgical. The system allows surgeons to use only the number of arms needed for a given procedure and is designed to integrate into existing workflows, it added.
With 3D HD vision, adaptive instrument control, and a choice of ergonomic working positions, the system’s open surgeon console could reduce stress and fatigue, the company added. It also allows for clear communication with the surgical team.
“By thinking laparoscopically and operating robotically with Versius, patients, surgeons, and healthcare professionals can all benefit from the value that robotic MAS brings,” CMR asserted.
In addition to performing surgeries, Versius can capture data with its wider digital ecosystem to support a surgeon’s continuous learning. Through the Versius Connect app, Versius Trainer, and CMR clinical registry, Versius can provide insights insights to ultimately improve surgical care, said CMR.
CMR Surgical sees increasing adoption
Versius is the second most-used soft-tissue surgical robot in the world, said CMR, with application across specialties including colorectal, general, gynecological, thoracic, and urology surgeries. The company attributed the increase in Versius installations to increasing adoption of surgical robotics, saying it validates the versatility of its system and strong market differentiation.
CMR is also actively expanding its clinical footprint with two ongoing clinical trials. First is a multicenter prospective trial on the use of Versius in pediatric surgery. Second is a transoral robotic surgery (TORS) trial to further demonstrate the versatility and capability of Versius in new applications.
CMR Surgical was featured in MassDevice‘s list of the 10 surgical robotic companies to watch in 2025.
CMR expects to continue rapid growth
All of CMR Surgical’s existing major investors participated in its latest funding round. It also included a new debt investment from Trinity Capital. Armentum Partners acted as CMR’s financial advisor on the debt financing.
“Trinity Capital is excited to partner with CMR Surgical at this important juncture,” said Rob Lake, senior managing director of life sciences at Trinity Capital. “CMR has established itself as a trailblazer in surgical robotics, with Versius already proving its value to surgeons and patients worldwide.”
“We are confident in CMR’s vision and leadership, and our investment reflects our belief that Versius will continue to drive a new era in minimally invasive surgery,” he said. “We look forward to supporting CMR as it continues to scale and transform surgical care on a global level.”
Lord Vallance, the U.K. science minister and Oxford-Cambridge Corridor champion, commented: “This successful funding round of more than $200 million is a clear vote of confidence in the company, the potential of surgical robotics, and in the U.K.’s life science ecosystem, which continues to produce innovative companies at an impressive rate. We will continue to back world-class innovation and companies like CMR Surgical as they realize their global ambitions and support the creation of high-quality jobs in the U.K.”
CMR said it will use the funds to accelerate commercial expansion of Versius to more hospitals around the world, with a major focus on the U.S. market. It also plans to continue advancing surgical robotics innovation and product development.
“I would like to give thanks to our CFO, Andre Nel, and the team for securing this financing to provide the foundation for realizing our strategic vision of making robotic-assisted surgery accessible to all patients who need it whilst accelerating future product development,” Colella said. “I would also like to thank our investors for their continued support and look forward to delivering sustainable growth and life-changing solutions to the global healthcare community.“
Learn more about surgical robots at the Robotics Summit
To learn more about the latest surgical robot advancements, the 2025 Robotics Summit & Expo on April 30 and May 1 will feature a track dedicated to healthcare robots. The show takes place at the Boston Convention and Exhibition Center and is co-located with DeviceTalks.
This year, the summit’s healthcare track will feature talks from both component and full system providers. These include Novanta, RTI, ForceN, and the latest cohort in MassRobotics‘ Healthcare Robotics Startup Catalyst.
DeviceTalks Boston is the premier event for medical technology professionals, currently in its tenth year. Both events attract engineering and business professionals from a broad range of healthcare and medical technology backgrounds.
The Robotics Summit & Expo is produced by WTWH Media, parent company of The Robot Report and MassDevice. It will bring together more than 5,000 attendees focused on building commercial robots for various industries. Attendees can gain insights into the latest enabling technologies, engineering best practices, emerging trends, and more.
Tell Us What You Think!